Long-term macrolide therapy in chronic inflammatory airway diseases

Crosbie P. A. J., Woodhead M. A.

Source: Eur Respir J 2009; 33: 171-181
Journal Issue: January
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Crosbie P. A. J., Woodhead M. A.. Long-term macrolide therapy in chronic inflammatory airway diseases. Eur Respir J 2009; 33: 171-181

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Anti-inflammatory therapies in bronchiectasis
Source: Eur Respir Mon 2011; 52: 223-238
Year: 2011


Severe therapy resistant asthma
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=312
Year: 2003

Macrolides, mucoactive drugs and adherence for the management of bronchiectasis
Source: Eur Respir J, 51 (1) 1701987; 10.1183/13993003.01987-2017
Year: 2018



Macrolides, mucoactive drugs and adherence for the management of bronchiectasis
Source: Eur Respir J, 51 (1) 1702033; 10.1183/13993003.02033-2017
Year: 2018



Macrolide effects on the prevention of COPD exacerbations
Source: Eur Respir J 2012; 40: 485-494
Year: 2012



Long-term macrolide treatment for chronic respiratory disease
Source: Eur Respir J 2013; 42: 239-251
Year: 2013



Azithromycin in the anti-inflammatory treatment of children with asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 167s
Year: 2004

Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis
Source: Eur Respir J, 54 (1) 1801896; 10.1183/13993003.01896-2018
Year: 2019



Inhaled antibiotics in chronic airway infections
Source: Eur Respir Monogr 2017; 75: 57-79
Year: 2017


Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD
Source: Eur Respir J 2009; 34: 1066-1071
Year: 2009



Neomacrolides in airway disease
Source: Annual Congress 2005 - New developments in infectious disease
Year: 2005

Bacteria, antibiotics and COPD
Source: Eur Respir J 2001; 17: 995-1007
Year: 2001



Anti-inflammatory properties of nimesulide and clarithromycin: a comparative study during the therapy of bronchial sepsis involving P.aeruginosa
Source: Eur Respir J 2002; 20: Suppl. 38, 373s
Year: 2002

Immunomodulatory properties of macrolide antibiotics in the treatment of bronchial sepsis involving P. aeruginosa
Source: Eur Respir J 2004; 24: Suppl. 48, 639s
Year: 2004

Anti-inflammatory therapy in cystic fibrosis: a comparative study in the treatment with nimesulide (selective cyclooxygenase-2 inhibitor) and clarithromycin (14-membered ring macrolide antibiotic)
Source: Eur Respir J 2004; 24: Suppl. 48, 615s
Year: 2004

Long-term macrolide therapy for non-CF bronchiectasis
Source: Annual Congress 2013 –ERS/JAMA Lunchtime session "Advances in IPF, bronchiectasis and sarcoidosis"
Year: 2013


Antibiotic treatment and prevention of exacerbations of COPD
Source: Eur Respir Monogr 2013; 60: 96-106
Year: 2013


Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma
Source: Eur Respir J 2004; 23: 714-717
Year: 2004



Macrolides as anti-inflammatory agents in CAP
Source: Eur Respir Monogr 2014; 63: 243-255
Year: 2014